The Effect of Panax Notoginseng Powders on Rheumatic Pain
NCT ID: NCT02260336
Last Updated: 2017-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2014-10-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Compliance of Traditional Chinese Medicine in Young Patients With Rheumatic Diseases
NCT02260323
Effects of HMG-coA Reductase Inhibitor on Rheumatoid Arthritis
NCT00555230
Effectiveness of Multigrain Supplementation Among the Rheumatoid Arthritis Patients
NCT04033809
Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis
NCT00432484
Impact of a High-fiber Diet on the Microbiome and Disease Activity in Patients With Rheumatoid Arthritis
NCT06492200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Panax Notoginseng Powder 1g
Panax Notoginseng Powder 1g, daily
Panax Notoginseng Powder 1g
Panax Notoginseng Powder 5g
Panax Notoginseng Powder 5g,daily
Panax Notoginseng Powder 5g
Panax Notoginseng Powder 10g
Panax Notoginseng Powder 10g,daily
Panax Notoginseng Powder 10g
Panax Notoginseng Powder 15g
Panax Notoginseng Powder 15g,daily
Panax Notoginseng Powder 15g
Celecoxib Capsule 400 mg daily
Celecoxib Capsule 400 mg daily
Celecoxib Capsule 400 mg daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Panax Notoginseng Powder 1g
Panax Notoginseng Powder 5g
Panax Notoginseng Powder 10g
Panax Notoginseng Powder 15g
Celecoxib Capsule 400 mg daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* without conflict to the written, informed consent signed prior to the enrollment.
Exclusion Criteria
* organic brain syndrome
* major psychiatric disturbances
* major communicative disorders
* a history of severe noncompliance
* less than 7 years of formal education, or illiteracy
* being included in other clinical trial within the last 4 weeks
* with abnormal liver or kidney function (more than 1 time above the high normal)
* with serious cardiovascular disease
* with hematologic disease
* being in pregnancy, lactation period or under a pregnancy plan
* with severe gastrointestinal disease
* with contraindication or being allergic to the test drugs
* being under the treatment of drugs within 1 previous week, that might affect the results of the trial, such as non-steroidal anti-inflammatory drugs
* being not compatible for the trial medication, or other circumstances at the discretion of investigators
* without legal capacity or only with limited legal capacity
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chengdu PLA General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yang Min
Ph.D
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
270 Rongdu street, Jin-niu district,Rheumatology Center of Integrated Medicine, General Hospital of Chengdu Military Area Command PLA，
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PNP01RP001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.